According to Ascendis press release, Yorvipath is the first treatment for hypoparathyroidism in adults
And the fact that these regimens continue to fail should tell us something
Related Reading Temporary Glp 1 Provider While Prior Authorization Pending Plexusdx Glp 1 Medications Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
NakaiKYonedaKMaedaRMunehiroAFujitaNYokoiIet alUrinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
So an effective way to stop the formation of 5-alpha reductase (and reducing DHT) is to Compete with the coenzyme NADPH, or Block NADPH These are two mechanisms of direct 5-alpha reductase inhibition or for the lay person reducing 5-alpha reductase by stopping it from forming